{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:07:36Z","timestamp":1790478456216,"version":"4.1.0"},"reference-count":166,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005972","name":"German Cancer Aid","doi-asserted-by":"crossref","award":["110442"],"award-info":[{"award-number":["110442"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005972","name":"German Cancer Aid","doi-asserted-by":"crossref","award":["111455"],"award-info":[{"award-number":["111455"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.imbio.2015.07.012","type":"journal-article","created":{"date-parts":[[2015,7,26]],"date-time":"2015-07-26T17:46:22Z","timestamp":1437932782000},"page":"11-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":171,"title":["Tricking the balance: NK cells in anti-cancer immunity"],"prefix":"10.1016","volume":"222","author":[{"given":"Jens","family":"Pahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelheid","family":"Cerwenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2015.07.012_bib0005","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1182\/blood-2009-10-248609","article-title":"Long-lasting antitumor protection by anti-CD20 antibody through cellular immune response","volume":"116","author":"Abes","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2015.07.012_bib0010","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1038\/nm.3013","article-title":"NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors","volume":"18","author":"Alvarez-Breckenridge","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.imbio.2015.07.012_bib0015","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2006.06.013","article-title":"Human NK cell education by inhibitory receptors for MHC class I","volume":"25","author":"Anfossi","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.imbio.2015.07.012_bib0020","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1172\/JCI74337","article-title":"Cytokine therapy reverses NK cell anergy in MHC-deficient tumors","volume":"124","author":"Ardolino","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2015.07.012_bib0025","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood-2003-05-1716","article-title":"The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46","volume":"103","author":"Arnon","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2015.07.012_bib0030","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/sj.bjc.6602930","article-title":"Trastuzumab-based treatment of HER2-positive breast cancer: an antibody-dependent cellular cytotoxicity mechanism?","volume":"94","author":"Arnould","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.imbio.2015.07.012_bib0035","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature14189","article-title":"The biology of innate lymphoid cells","volume":"517","author":"Artis","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2015.07.012_bib0040","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.4049\/jimmunol.173.2.1078","article-title":"Two human ULBP\/RAET1 molecules with transmembrane regions are ligands for NKG2D","volume":"173","author":"Bacon","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0045","doi-asserted-by":"crossref","first-page":"17450","DOI":"10.1073\/pnas.1304790110","article-title":"Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia","volume":"110","author":"Baginska","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.imbio.2015.07.012_bib0050","doi-asserted-by":"crossref","first-page":"20847","DOI":"10.1073\/pnas.0906481106","article-title":"Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity","volume":"106","author":"Balsamo","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.imbio.2015.07.012_bib0055","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.285.5428.727","article-title":"Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA","volume":"285","author":"Bauer","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.imbio.2015.07.012_bib0060","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1182\/blood-2013-03-489054","article-title":"Identification of a cellular ligand for the natural cytotoxicity receptor NKp44","volume":"122","author":"Baychelier","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2015.07.012_bib0065","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/ni.2876","article-title":"The transcription factor Zbtb32 controls the proliferative burst of virus-specific natural killer cells responding to infection","volume":"15","author":"Beaulieu","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0070","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1182\/blood-2012-10-459545","article-title":"NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs","volume":"121","author":"Beziat","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2015.07.012_bib0075","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1200\/JCO.2008.18.0463","article-title":"Impact of Fc{gamma}RIIa-Fc{gamma}RIIIa polymorphisms and KRAS mutations on the clinical outcome of patients with metastatic colorectal cancer treated with cetuximab plus irinotecan","volume":"27","author":"Bibeau","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0080","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1182\/blood-2010-04-281675","article-title":"Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education","volume":"116","author":"Bjorkstrom","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2015.07.012_bib0085","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1084\/jem.20030788","article-title":"Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule","volume":"198","author":"Bottino","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2015.07.012_bib0090","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1084\/jem.20090681","article-title":"The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans","volume":"206","author":"Brandt","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2015.07.012_bib0095","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/35869","article-title":"HLA-E binds to natural killer cell receptors CD94\/NKG2A, B and C","volume":"391","author":"Braud","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2015.07.012_bib0100","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature10358","article-title":"Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans","volume":"477","author":"Breitbach","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2015.07.012_bib0105","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.4049\/jimmunol.1401224","article-title":"PTEN is a negative regulator of NK cell cytolytic function","volume":"194","author":"Briercheck","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0110","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.4049\/jimmunol.0901226","article-title":"Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells","volume":"183","author":"Carlsten","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0115","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1126\/science.aaa3828","article-title":"Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells","volume":"348","author":"Carreno","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.imbio.2015.07.012_bib0120","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/blood.V99.3.754","article-title":"Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene","volume":"99","author":"Cartron","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2015.07.012_bib0125","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1074-7613(00)80222-8","article-title":"Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice","volume":"12","author":"Cerwenka","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.imbio.2015.07.012_bib0130","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1073\/pnas.201238598","article-title":"Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo","volume":"98","author":"Cerwenka","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.imbio.2015.07.012_bib0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/35095564","article-title":"Natural killer cells, viruses and cancer","volume":"1","author":"Cerwenka","year":"2001","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0140","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0006-291X(03)00714-9","article-title":"ULBP4 is a novel ligand for human NKG2D","volume":"305","author":"Chalupny","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.imbio.2015.07.012_bib0145","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/ni.2850","article-title":"The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions","volume":"15","author":"Chan","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0150","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/leu.2013.279","article-title":"CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma","volume":"28","author":"Chu","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.imbio.2015.07.012_bib0155","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.4049\/jimmunol.180.11.7249","article-title":"Human tumor-derived exosomes down-modulate NKG2D expression","volume":"180","author":"Clayton","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0160","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1073\/pnas.0813192106","article-title":"Cytokine-induced memory-like natural killer cells","volume":"106","author":"Cooper","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.imbio.2015.07.012_bib0165","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1074-7613(01)00095-4","article-title":"ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor","volume":"14","author":"Cosman","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.imbio.2015.07.012_bib0170","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1182\/blood.V99.10.3661","article-title":"Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia","volume":"99","author":"Costello","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2015.07.012_bib0175","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1182\/blood-2007-07-100057","article-title":"Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways","volume":"111","author":"Coudert","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2015.07.012_bib0180","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1182\/blood-2005-03-0918","article-title":"Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells","volume":"106","author":"Coudert","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2015.07.012_bib0185","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.immuni.2014.05.003","article-title":"Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1","volume":"40","author":"Crouse","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.imbio.2015.07.012_bib0190","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1182\/blood-2011-01-329508","article-title":"Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients","volume":"118","author":"Curti","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2015.07.012_bib0195","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1158\/0008-5472.CAN-03-2862","article-title":"Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship","volume":"64","author":"Dall\u2019Ozzo","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.imbio.2015.07.012_bib0200","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4049\/jimmunol.123.1.252","article-title":"Evidence that natural cytotoxicity and antibody-dependent cellular cytotoxicity are mediated in humans by the same effector cell populations","volume":"123","author":"de Landazuri","year":"1979","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0205","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.4049\/jimmunol.1302053","article-title":"Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C\u2212\/\u2212 umbilical cord blood","volume":"192","author":"Della Chiesa","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0210","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1126\/science.1258867","article-title":"Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection","volume":"348","author":"Deng","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.imbio.2015.07.012_bib0215","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/77793","article-title":"Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages","volume":"1","author":"Diefenbach","year":"2000","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0220","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/35093109","article-title":"Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity","volume":"413","author":"Diefenbach","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2015.07.012_bib0225","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1002\/eji.200939502","article-title":"ULBP6\/RAET1L is an additional human NKG2D ligand","volume":"39","author":"Eagle","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0230","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1084\/jem.20100986","article-title":"MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment","volume":"207","author":"Elliott","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2015.07.012_bib0235","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/blood-2005-08-027979","article-title":"Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction","volume":"109","author":"Fauriat","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2015.07.012_bib0240","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1084\/jem.20011149","article-title":"Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells","volume":"195","author":"Ferlazzo","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2015.07.012_bib0245","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1182\/blood-2013-02-482513","article-title":"Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells","volume":"122","author":"Fiegler","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2015.07.012_bib0250","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.4049\/jimmunol.1201964","article-title":"Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen","volume":"189","author":"Foley","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0255","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.aaa4972","article-title":"Cancer and the microbiota","volume":"348","author":"Garrett","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.imbio.2015.07.012_bib0260","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/nature03884","article-title":"The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor","volume":"436","author":"Gasser","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2015.07.012_bib0265","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1600-065X.2006.00460.x","article-title":"Activation and self-tolerance of natural killer cells","volume":"214","author":"Gasser","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imbio.2015.07.012_bib0270","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1084\/jem.20122462","article-title":"IL-2-dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells","volume":"210","author":"Gasteiger","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2015.07.012_bib0275","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2217\/imt.11.131","article-title":"Use of allogeneic NK cells for cancer immunotherapy","volume":"3","author":"Geller","year":"2011","journal-title":"Immunotherapy"},{"key":"10.1016\/j.imbio.2015.07.012_bib0280","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1158\/1078-0432.CCR-04-0225","article-title":"Pilot study of the mechanism of action of preoperative trastuzumab in patients with primary operable breast tumors overexpressing HER2","volume":"10","author":"Gennari","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.imbio.2015.07.012_bib0285","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1158\/1078-0432.CCR-12-0989","article-title":"GA201 (RG7160): a novel, humanized, glycoengineered anti-EGFR antibody with enhanced ADCC and superior in vivo efficacy compared with cetuximab","volume":"19","author":"Gerdes","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.imbio.2015.07.012_bib0290","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ccr.2013.01.008","article-title":"Role of macrophage targeting in the antitumor activity of trabectedin","volume":"23","author":"Germano","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.imbio.2015.07.012_bib0295","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nature01112","article-title":"Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation","volume":"419","author":"Groh","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2015.07.012_bib0300","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.immuni.2015.01.010","article-title":"Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack","volume":"42","author":"Gur","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.imbio.2015.07.012_bib0305","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nm.3089","article-title":"Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer","volume":"19","author":"Heo","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.imbio.2015.07.012_bib0310","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1126\/science.7025208","article-title":"Natural killer cells: their roles in defenses against disease","volume":"214","author":"Herberman","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.imbio.2015.07.012_bib0315","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.4049\/jimmunol.1200796","article-title":"Comprehensive analysis of NKG2D ligand expression and release in leukemia: implications for NKG2D-mediated NK cell responses","volume":"189","author":"Hilpert","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0320","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2015.07.012_bib0325","doi-asserted-by":"crossref","first-page":"208ra145","DOI":"10.1126\/scitranslmed.3006702","article-title":"Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry","volume":"5","author":"Horowitz","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.imbio.2015.07.012_bib0330","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/ni1487","article-title":"Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1","volume":"8","author":"Huntington","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0335","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(00)03231-1","article-title":"Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population","volume":"356","author":"Imai","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.imbio.2015.07.012_bib0340","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1158\/0008-5472.CAN-14-2788","article-title":"CTLA-4+ regulatory T cells increased in cetuximab-treated head and neck cancer patients suppress NK cell cytotoxicity and correlate with poor prognosis","volume":"75","author":"Jie","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.imbio.2015.07.012_bib0345","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1084\/jem.20100570","article-title":"Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment","volume":"207","author":"Joncker","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2015.07.012_bib0350","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1182\/blood-2009-11-253286","article-title":"CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells","volume":"116","author":"Juelke","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2015.07.012_bib0355","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.4049\/jimmunol.169.4.1948","article-title":"Role that each NKG2A immunoreceptor tyrosine-based inhibitory motif plays in mediating the human CD94\/NKG2A inhibitory signal","volume":"169","author":"Kabat","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0360","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.cell.2014.08.026","article-title":"The RAG recombinase dictates functional heterogeneity and cellular fitness in natural killer cells","volume":"159","author":"Karo","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.imbio.2015.07.012_bib0365","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/319675a0","article-title":"Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy","volume":"319","author":"Karre","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2015.07.012_bib0370","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ni746","article-title":"Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection","volume":"3","author":"Kelly","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0375","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/eji.1830050209","article-title":"\u201cNatural\u201d killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell","volume":"5","author":"Kiessling","year":"1975","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0380","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature03847","article-title":"Licensing of natural killer cells by host major histocompatibility complex class I molecules","volume":"436","author":"Kim","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2015.07.012_bib0385","first-page":"309","article-title":"Immunotherapy of cancer in 2012","volume":"62","author":"Kirkwood","year":"2012","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.imbio.2015.07.012_bib0390","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1182\/blood.V90.3.1109","article-title":"Fc gammaRIIIa-158V\/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L\/R\/H phenotype","volume":"90","author":"Koene","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2015.07.012_bib0391","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1182\/blood-2010-08-301945","article-title":"CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies","volume":"117","author":"Kohrt","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2015.07.012_bib0392","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1172\/JCI61226","article-title":"Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer","volume":"122","author":"Kohrt","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2015.07.012_bib0395","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1182\/blood-2013-08-519199","article-title":"Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies","volume":"123","author":"Kohrt","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2015.07.012_bib0400","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1084\/jem.20021836","article-title":"Interleukin (IL)-15R[alpha]-deficient natural killer cells survive in normal but not IL-15R[alpha]-deficient mice","volume":"197","author":"Koka","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2015.07.012_bib0405","doi-asserted-by":"crossref","first-page":"6593","DOI":"10.1182\/blood-2009-01-201467","article-title":"NK-cell-mediated killing of target cells triggers robust antigen-specific T-cell-mediated and humoral responses","volume":"113","author":"Krebs","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2015.07.012_bib0410","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature14426","article-title":"Mutant MHC class II epitopes drive therapeutic immune responses to cancer","volume":"520","author":"Kreiter","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2015.07.012_bib0415","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ceb.2008.05.006","article-title":"The killer's kiss: the many functions of NK cell immunological synapses","volume":"20","author":"Krzewski","year":"2008","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0420","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.4049\/jimmunol.141.10.3478","article-title":"Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes","volume":"141","author":"Lanier","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0425","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.4049\/jimmunol.175.9.5790","article-title":"NK cells infiltrating a MHC class I-deficient lung adenocarcinoma display impaired cytotoxic activity toward autologous tumor cells associated with altered NK cell-triggering receptors","volume":"175","author":"Le Maux Chansac","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0430","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.immuni.2015.02.013","article-title":"Epigenetic modification and antibody-dependent expansion of memory-like NK cells in Human cytomegalovirus-infected Individuals","volume":"42","author":"Lee","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.imbio.2015.07.012_bib0435","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.4049\/jimmunol.172.12.7335","article-title":"Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients","volume":"172","author":"Lee","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0440","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bbmt.2014.01.006","article-title":"Preactivation with IL-12, IL-15, and IL-18 induces CD25 and a functional high-affinity IL-2 receptor on human cytokine-induced memory-like natural killer cells","volume":"20","author":"Leong","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.imbio.2015.07.012_bib0445","doi-asserted-by":"crossref","first-page":"E700","DOI":"10.1073\/pnas.1413886112","article-title":"PTEN regulates natural killer cell trafficking in vivo","volume":"112","author":"Leong","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.imbio.2015.07.012_bib0450","doi-asserted-by":"crossref","first-page":"14725","DOI":"10.1073\/pnas.1110900108","article-title":"Expansion of a unique CD57(+)NKG2Chi natural killer cell subset during acute human cytomegalovirus infection","volume":"108","author":"Lopez-Verges","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.imbio.2015.07.012_bib0455","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.immuni.2007.03.006","article-title":"Dendritic cells prime natural killer cells by trans-presenting interleukin 15","volume":"26","author":"Lucas","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.imbio.2015.07.012_bib0460","doi-asserted-by":"crossref","first-page":"e1004441","DOI":"10.1371\/journal.ppat.1004441","article-title":"Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells","volume":"10","author":"Luetke-Eversloh","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.imbio.2015.07.012_bib0465","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/1471-2407-10-340","article-title":"Putative contribution of CD56 positive cells in cetuximab treatment efficacy in first-line metastatic colorectal cancer patients","volume":"10","author":"Marechal","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.imbio.2015.07.012_bib0470","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nri3799","article-title":"Balancing natural killer cell activation through paired receptors","volume":"15","author":"Martinet","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0475","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1071059","article-title":"The danger model: a renewed sense of self","volume":"296","author":"Matzinger","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.imbio.2015.07.012_bib0480","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1182\/blood-2013-11-492231","article-title":"Antibody-modified T cells: CARs take the front seat for hematologic malignancies","volume":"123","author":"Maus","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2015.07.012_bib0485","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","article-title":"Cancer immunotherapy comes of age","volume":"480","author":"Mellman","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2015.07.012_bib0490","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1158\/0008-5472.CAN-14-0303","article-title":"ITPR1 protects renal cancer cells against natural killer cells by inducing autophagy","volume":"74","author":"Messai","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.imbio.2015.07.012_bib0495","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1084\/jem.20132459","article-title":"Proapoptotic Bim regulates antigen-specific NK cell contraction and the generation of the memory NK cell pool after cytomegalovirus infection","volume":"211","author":"Min-Oo","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2015.07.012_bib0500","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.smim.2006.03.002","article-title":"Surface NK receptors and their ligands on tumor cells","volume":"18","author":"Moretta","year":"2006","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0505","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1182\/blood-2008-01-135319","article-title":"Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines","volume":"112","author":"Morse","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2015.07.012_bib0510","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1200\/JCO.2007.14.8957","article-title":"Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2\/neu-positive metastatic breast cancer","volume":"26","author":"Musolino","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0515","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.immuni.2013.12.011","article-title":"Costimulatory molecule DNAM-1 is essential for optimal differentiation of memory natural killer cells during mouse cytomegalovirus infection","volume":"40","author":"Nabekura","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.imbio.2015.07.012_bib0520","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1126\/science.1215621","article-title":"Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses","volume":"335","author":"Narni-Mancinelli","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.imbio.2015.07.012_bib0525","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1084\/jem.20120944","article-title":"Sustained effector function of IL-12\/15\/18-preactivated NK cells against established tumors","volume":"209","author":"Ni","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2015.07.012_bib0530","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/ni1332","article-title":"T cell- and B cell-independent adaptive immunity mediated by natural killer cells","volume":"7","author":"O\u2019Leary","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0535","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/ni1239","article-title":"Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance","volume":"6","author":"Oppenheim","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0540","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1084\/jem.20112124","article-title":"The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses","volume":"209","author":"Pachynski","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2015.07.012_bib0545","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1158\/1078-0432.CCR-11-2277","article-title":"Anti-EGFR antibody cetuximab enhances the cytolytic activity of natural killer cells toward osteosarcoma","volume":"18","author":"Pahl","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.imbio.2015.07.012_bib0550","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00262-013-1406-x","article-title":"Antibody-dependent cell lysis by NK cells is preserved after sarcoma-induced inhibition of NK cell cytotoxicity","volume":"62","author":"Pahl","year":"2013","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.imbio.2015.07.012_bib0555","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nature12998","article-title":"The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells","volume":"507","author":"Paolino","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2015.07.012_bib0560","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ccr.2010.06.014","article-title":"The therapeutic effect of anti-HER2\/neu antibody depends on both innate and adaptive immunity","volume":"18","author":"Park","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.imbio.2015.07.012_bib0565","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1158\/1078-0432.CCR-11-1347","article-title":"Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression","volume":"17","author":"Parkhurst","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.imbio.2015.07.012_bib0570","doi-asserted-by":"crossref","DOI":"10.1038\/leu.2015.88","article-title":"Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia","author":"Parrish","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.imbio.2015.07.012_bib0575","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/ni.1953","article-title":"Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses","volume":"11","author":"Paust","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0580","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1158\/0008-5472.CAN-11-2544","article-title":"Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity","volume":"72","author":"Pietra","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.imbio.2015.07.012_bib0585","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.4049\/jimmunol.0901074","article-title":"Reciprocal human dendritic cell-natural killer cell interactions induce antitumor activity following tumor cell infection by oncolytic reovirus","volume":"183","author":"Prestwich","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0590","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10138","article-title":"CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis","volume":"475","author":"Qian","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2015.07.012_bib0595","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood-2013-01-476606","article-title":"Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity","volume":"121","author":"Reiners","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2015.07.012_bib0600","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1172\/JCI77440","article-title":"IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion","volume":"124","author":"Rolle","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2015.07.012_bib0605","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1182\/blood-2012-04-419283","article-title":"Cytokine activation induces human memory-like NK cells","volume":"120","author":"Romee","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2015.07.012_bib0610","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1126\/science.aaa4967","article-title":"Adoptive cell transfer as personalized immunotherapy for human cancer","volume":"348","author":"Rosenberg","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.imbio.2015.07.012_bib0615","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1200\/JCO.2009.24.4590","article-title":"NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia","volume":"28","author":"Rubnitz","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0620","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.imbio.2015.07.012_bib0625","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1158\/0008-5472.CAN-13-0371","article-title":"Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors","volume":"73","author":"Rusakiewicz","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.imbio.2015.07.012_bib0630","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.1038\/ncomms7375","article-title":"Generation of cellular immune memory and B-cell immunity is impaired by natural killer cells","volume":"6","author":"Rydyznski","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.imbio.2015.07.012_bib0635","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.4049\/jimmunol.169.8.4098","article-title":"Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding","volume":"169","author":"Salih","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0640","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1158\/0008-5472.CAN-13-3017","article-title":"Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30","volume":"74","author":"Schlecker","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.imbio.2015.07.012_bib0645","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.immuni.2015.02.008","article-title":"Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function","volume":"42","author":"Schlums","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.imbio.2015.07.012_bib0650","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/mt.2014.219","article-title":"Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2\/HER2-specific chimeric antigen receptor","volume":"23","author":"Schonfeld","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.imbio.2015.07.012_bib0655","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.imbio.2015.07.012_bib0660","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.imbio.2015.07.012_bib0665","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.immuni.2014.09.013","article-title":"TRAIL+ NK cells control CD4+ T cell responses during chronic viral infection to limit autoimmunity","volume":"41","author":"Schuster","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.imbio.2015.07.012_bib0670","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.molimm.2004.07.034","article-title":"Activation of NK cell cytotoxicity","volume":"42","author":"Smyth","year":"2005","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0675","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1084\/jem.20050994","article-title":"NKG2D function protects the host from tumor initiation","volume":"202","author":"Smyth","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2015.07.012_bib0680","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.4049\/jimmunol.1004122","article-title":"Cutting edge: CD8+ T cell priming in the absence of NK cells leads to enhanced memory responses","volume":"186","author":"Soderquest","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0685","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1158\/1078-0432.CCR-12-2426","article-title":"Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients","volume":"19","author":"Srivastava","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.imbio.2015.07.012_bib0690","doi-asserted-by":"crossref","first-page":"17858","DOI":"10.1073\/pnas.0903474106","article-title":"The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity","volume":"106","author":"Stanietsky","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.imbio.2015.07.012_bib0695","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000325465","article-title":"Natural killer cells and solid tumors","volume":"3","author":"Stojanovic","year":"2011","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.imbio.2015.07.012_bib0700","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature07665","article-title":"Adaptive immune features of natural killer cells","volume":"457","author":"Sun","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2015.07.012_bib0705","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1084\/jem.20111760","article-title":"Proinflammatory cytokine signaling required for the generation of natural killer cell memory","volume":"209","author":"Sun","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2015.07.012_bib0710","first-page":"1295","article-title":"Immunological memory within the innate immune system","volume":"33","author":"Sun","year":"2014","journal-title":"EMBO J."},{"key":"10.1016\/j.imbio.2015.07.012_bib0715","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1172\/JCI62749","article-title":"Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment","volume":"122","author":"Tarek","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2015.07.012_bib0720","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.coi.2012.01.001","article-title":"NK cell MHC class I specific receptors (KIR): from biology to clinical intervention","volume":"24","author":"Thielens","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0725","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2015.07.012_bib0730","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1084\/jem.20131601","article-title":"CD160 is essential for NK-mediated IFN-gamma production","volume":"212","author":"Tu","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2015.07.012_bib0735","doi-asserted-by":"crossref","first-page":"e26097","DOI":"10.4161\/onci.26097","article-title":"New prospects on the NKG2D\/NKG2DL system for oncology","volume":"2","author":"Ullrich","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.imbio.2015.07.012_bib0740","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.4049\/jimmunol.151.11.6429","article-title":"Binding of monomeric human IgG defines an expression polymorphism of Fc gamma RIII on large granular lymphocyte\/natural killer cells","volume":"151","author":"Vance","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0745","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1182\/blood-2011-05-351411","article-title":"Rituximab infusion induces NK activation in lymphoma patients with the high-affinity CD16 polymorphism","volume":"118","author":"Veeramani","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2015.07.012_bib0750","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1158\/0008-5472.CAN-14-0987","article-title":"Harnessing the intestinal microbiome for optimal therapeutic immunomodulation","volume":"74","author":"Viaud","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.imbio.2015.07.012_bib0755","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/eji.201344272","article-title":"Effect of tumor cells and tumor microenvironment on NK-cell function","volume":"44","author":"Vitale","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0760","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4049\/jimmunol.146.1.206","article-title":"Tyrosine phosphorylation of the Fc gamma RIII(CD16): zeta complex in human natural killer cells. Induction by antibody-dependent cytotoxicity but not by natural killing","volume":"146","author":"Vivier","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0765","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.imbio.2015.07.012_bib0770","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0775","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nature10624","article-title":"Natural killer cells act as rheostats modulating antiviral T cells","volume":"481","author":"Waggoner","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2015.07.012_bib0780","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1128\/JVI.03002-13","article-title":"Therapeutic depletion of natural killer cells controls persistent infection","volume":"88","author":"Waggoner","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0785","doi-asserted-by":"crossref","first-page":"8437","DOI":"10.1158\/0008-5472.CAN-08-1440","article-title":"Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands","volume":"68","author":"Wendel","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.imbio.2015.07.012_bib0790","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1200\/JCO.2003.05.013","article-title":"Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma","volume":"21","author":"Weng","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.imbio.2015.07.012_bib0795","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1302369","article-title":"Nivolumab plus ipilimumab in advanced melanoma","volume":"369","author":"Wolchok","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2015.07.012_bib0800","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.stem.2014.01.020","article-title":"Clonal tracking of rhesus macaque hematopoiesis highlights a distinct lineage origin for natural killer cells","volume":"14","author":"Wu","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.imbio.2015.07.012_bib0805","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.immuni.2014.05.004","article-title":"Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity","volume":"40","author":"Xu","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.imbio.2015.07.012_bib0810","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/mt.2012.184","article-title":"Cetuximab-mediated tumor regression depends on innate and adaptive immune responses","volume":"21","author":"Yang","year":"2013","journal-title":"Mol. Ther."},{"issue":"226","key":"10.1016\/j.imbio.2015.07.012_bib0815","doi-asserted-by":"crossref","first-page":"ra232","DOI":"10.1126\/scitranslmed.3008095","article-title":"Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy","volume":"6","author":"Zamarin","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.imbio.2015.07.012_bib0820","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1200\/JCO.2006.08.8021","article-title":"FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab","volume":"25","author":"Zhang","year":"2007","journal-title":"J. Clin. Oncol."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298515300310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298515300310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:42:11Z","timestamp":1759250531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298515300310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":166,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0171298515300310"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2015.07.012","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tricking the balance: NK cells in anti-cancer immunity","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2015.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}